跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ABIRATERONE VIATRIS abiraterone acetate 250 mg tablet bottle - TGA Drug Approval Details
Approvals
/
TGA
/
ABIRATERONE VIATRIS abiraterone acetate 250 mg tablet bottle
Approved
STANDARD
ABIRATERONE VIATRIS abiraterone acetate 250 mg tablet bottle
Glenmark Pharmaceuticals Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
445007de175ae16f
Company
Glenmark Pharmaceuticals Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
445007de175ae16f
Product Name
ABIRATERONE VIATRIS abiraterone acetate 250 mg tablet bottle
Artg Id
453789
Artg Name
ABIRATERONE VIATRIS abiraterone acetate 250 mg tablet bottle
Sponsor
Glenmark Pharmaceuticals Australia Pty Ltd
Company Detail Path
/organization/glenmark-pharmaceuticals-australia-pty-limited
Artg Date
2025-05-21
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
445007de175ae16f
Type
Standard
Back to TGA Approvals
